• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Flamel Technologies SA

+ Add to Watchlist

FLML:US

13.4300 USD 0.0600 0.44%

As of 11:57:57 ET on 07/31/2014.

Snapshot for Flamel Technologies SA (FLML)

Open: 13.2700 Day's Range: 13.2600 - 13.5000 Volume: 27,807
Previous Close: 13.4900 52wk Range: 5.3000 - 15.7500 1-Yr Rtn: +123.83%

Stock Chart for FLML

No chart data available.
  • FLML:US 13.4200
  • 1D
  • 1M
  • 1Y
13.4900
Interactive FLML Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FLML

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.0035
Est. EPS (USD) (12/2014) -0.5360
Est. PEG Ratio -
Market Cap (M USD) 489.82
Shares Outstanding (M) 36.42
30 Day Average Volume 249,140
Price/Book (mrq) -
Price/Sale (ttm) 13.4679
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FLML

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for FLML

Flamel Technologies SA manufactures pharmaceutical products. The Company develops drug delivery platforms for controlled release of injected biologics, small molecules drugs, oral liquid medicines, and vaccine formulations. Flamel Technologies conducts business worldwide.

Michael S Anderson "Mike"Chief Executive OfficerSian CrouzetPrincipal Financial Officer
Phil ThompsonSenior VP/General CounselSteven A LisiSenior VP:Bus & Corporate Dev
More Company Profile & Key Executives for FLML

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil